MedTrace Logo

Kineret in the Treatment of Rheumatoid Arthritis

NCT02915094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-08-11

No results posted yet for this study

Summary

Objective of the study is to gain knowledge about the administration of Kineret in patients with rheumatoid arthritis in the daily routine treatment and not in controlled trials. In the current survey, the investigation of the response rate of Kineret regarding the date of onset of action, the efficacy, as well as the tolerability and safety are of particular interest.

Conditions

Interventions

DRUG

Anakinra

Sponsors & Collaborators

  • Swedish Orphan Biovitrum

    lead INDUSTRY

Principal Investigators

  • Stefan Zeitler, MD · Swedish Orphan Biovitrum GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02915094 on ClinicalTrials.gov